Home Conference Coverage

Conference Coverage

Featured Image: Boston Public Garden; Boston, MA. Courtesy: © 2017 Fotolia. Used with permission.

Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 in Patients with...

Initial safety data of STRO-002 shows potent anti-tumor activity in preclinical endometrial cancer patient-derived xenograft (PDX) models were presented...
Gesso Italiano (Italian Chalk) in San Diego's Little Italy neighborhood celebrating its heritage by bringing the vibrancy and flavors of Italy to southern California. Courtesy: 2016 Fotolia.

Advanced Design of ADCs: Principles and Applications using Next Generation Linkers and Site-Specific Technology

Over the years there have been major challenges in the development of antibody-drug conjugates (ADC), including: choosing the right...
Featured Image - Laboratory. Courtesy 2019 Fotolia

Study Demonstrates Superior Efficacy and Cytotoxicity of Femtogenix’s Sequence-selective DNA-interactive Payload

Data verifying a favorable toxicity profile and potent efficacy of a novel pyrridinobenzodiazepine (PDD) antibody-drug conjugate payload platform in...
Featured Image - San Diego, CA at night. Courtesy 2019 Fotolia

Zymeworks Wins Best ADC Platform Technology Award for ZymeLink

Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics including bispecific antibodies and bispecific antibody-drug conjugates across a wide range...
Downtown San Diego, CA. Courtesy: 2019 David Cruz/Sunvalley Communication

Abzena to Offer New, Integrated, Clinical Translation Service

Abzena, a life sciences company providing a series of specific serviced for the development of antibody-drug conjugates, earlier this...
The AACR 2019 Annual Meeting - Poster Session during the American Association for Cancer Research (AACR) Annual Meeting, Sunday March 31, 2019. Courtesy: © AACR/Todd Buchanan 2019

Randall Schatzman, Ph.D. to Lead Growth of Immune-Stimulating Antibody Conjugates at Bolt Biotherapeutics

Veteran Executive Randall Schatzman, Ph.D. has been hired as the new Chief Executive Officer and a member of the...

Sutro Biopharma to Receive Milestone Payment from Merck KGaA for Bispecific ADC Candidate

Sutro Biopharma has achieved a milestone under its collaboration and license agreement with the healthcare division of Merck KGaA,...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Steffen Heeger, MD, Ph.D to Lead NBE-Therapeutics’ Clinical iADC Development

Privately-owned Swiss, Basel-based, NBE-Therapeutics has appointed Steffen Heeger MD, Ph.D. as Chief Medical Officer to lead the clinical development...

Comprehensive Service Accelerates Development of ADCs and Reduces Time to Clinic

A new service called ADC Express™services, launched by MilliporeSigma, allows for the rapid production of Antibody-drug Conjugates or ADCs....

World ADC 2019: Maximizing the Clinical Therapeutic Index of Antibody-drug Conjugates

With five approved and commercially available antibody-drug conjugates and nearly 100 in various stages of clinical development, it is...